News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,198 Results
Type
Article (14548)
Company Profile (38)
Press Release (181612)
Section
Business (55244)
Career Advice (615)
Deals (9944)
Drug Delivery (31)
Drug Development (32072)
Employer Resources (69)
FDA (5046)
Job Trends (4429)
News (102449)
Policy (8440)
Tag
Academia (1215)
Alliances (15856)
Alzheimer's disease (493)
Approvals (5019)
Artificial intelligence (46)
Bankruptcy (71)
Best Places to Work (3739)
Breast cancer (45)
Cancer (351)
Cardiovascular disease (37)
Career advice (515)
Cell therapy (93)
Clinical research (26088)
Collaboration (113)
COVID-19 (1180)
Data (424)
Diabetes (59)
Diagnostics (1830)
Drug pricing (31)
Earnings (15880)
Employer resources (63)
Events (24603)
Executive appointments (94)
FDA (5196)
Funding (121)
Gene therapy (54)
GLP-1 (236)
Government (1226)
Healthcare (5980)
Infectious disease (1213)
Inflammatory bowel disease (51)
Interviews (103)
IPO (3849)
Job creations (820)
Job search strategy (458)
Layoffs (77)
Legal (1583)
Lung cancer (51)
Manufacturing (53)
Medical device (3331)
Medtech (3333)
Mergers & acquisitions (6155)
Metabolic disorders (143)
Neuroscience (609)
NextGen Class of 2024 (2300)
Non-profit (1734)
Northern California (385)
Obesity (70)
Opinion (43)
Parkinson's disease (32)
People (19031)
Phase I (6531)
Phase II (11272)
Phase III (10062)
Pipeline (144)
Policy (30)
Postmarket research (1173)
Preclinical (2753)
Press Release (34)
Radiopharmaceuticals (65)
Rare diseases (71)
Real estate (1501)
Regulatory (6048)
Research institute (1054)
Resumes & cover letters (82)
Southern California (347)
Startups (1353)
United States (3577)
Vaccines (262)
Weight loss (52)
Date
Today (39)
Last 7 days (220)
Last 30 days (1010)
Last 365 days (10205)
2024 (9310)
2023 (11621)
2022 (15530)
2021 (17216)
2020 (16236)
2019 (15125)
2018 (11619)
2017 (10684)
2016 (10300)
2015 (12284)
2014 (8371)
2013 (6518)
2012 (6979)
2011 (7385)
2010 (6299)
Location
Africa (268)
Arizona (30)
Asia (13405)
Australia (2522)
California (849)
Canada (294)
China (88)
Colorado (41)
Connecticut (31)
Europe (35309)
Florida (130)
Georgia (48)
Illinois (102)
Indiana (58)
Japan (31)
Kansas (29)
Maryland (161)
Massachusetts (596)
Michigan (29)
Minnesota (70)
New Jersey (264)
New York (360)
North Carolina (176)
Northern California (385)
Ohio (33)
Pennsylvania (217)
South America (388)
Southern California (347)
Texas (122)
Washington State (143)
196,198 Results for "cellular biomedicine group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer
Nektar Therapeutics (Nasdaq: NKTR) announced today that it has entered into a new clinical study collaboration with Cellular Biomedicine Group Inc. (“CBMG”).
September 27, 2023
·
7 min read
Business
Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a worldwide collaboration and license agreement with Cellular Biomedicine Group Inc. (CBMG) to develop, manufacture and commercialize next-generation chimeric antigen receptor (CAR) T-cell therapies for the treatment of B-cell malignancies.
May 2, 2023
·
8 min read
Business
Cellular Biomedicine Group Announces Exclusive Collaboration and License Agreement with Janssen to Develop and Commercialize anti CD19 & CD20 Bi-Specific and anti CD20 CAR-Ts for Non-Hodgkin Lymphoma
Cellular Biomedicine Group Inc. (CBMG or the Company), a clinical-stage biopharmaceutical company focused on discovery and development of innovative cellular therapies for cancer and autoimmune diseases, today announced that the Company has entered into a global collaboration and license agreement with Janssen Biotech, Inc.
May 2, 2023
·
5 min read
Press Releases
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
November 20, 2024
·
1 min read
Press Releases
Bio-Path Holdings Announces Publication in Biomedicines
September 16, 2024
·
4 min read
Biotech Bay
Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
Innovent Biologics, Inc. provided interpretation and updates on clinical data from Mazdutide’s GLORY-1 study and its general biomedicine pipeline at an investor conference call on June 25.
June 27, 2024
·
9 min read
Biotech Beach
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument.
April 24, 2024
·
4 min read
Press Releases
First Patient Dosed in Endeavor BioMedicines’ Phase 2b WHISTLE-PF Trial Evaluating ENV-101 for the Treatment of Idiopathic Pulmonary Fibrosis
November 20, 2024
·
3 min read
Press Releases
Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
October 17, 2024
·
8 min read
Press Releases
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
November 5, 2024
·
10 min read
1 of 19,620
Next
